{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:50:45Z","timestamp":1767912645281,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s13730-020-00494-6","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T14:03:11Z","timestamp":1592402591000},"page":"395-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0002-3758","authenticated-orcid":false,"given":"Yoko","family":"Nishizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuho","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Horimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotsugu","family":"Omae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"494_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","volume":"15","author":"M Kawano","year":"2011","unstructured":"Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, Yamanaka N, Inoue D, Yamamoto M, Takahashi H, Nomura H, Taguchi T, Umehara H, Makino H, Saito T. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615\u201326.","journal-title":"Clin Exp Nephrol"},{"key":"494_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13075-017-1467-x","volume":"19","author":"K Yamada","year":"2017","unstructured":"Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, Hara S, Takahashi H, Nomura H, Kawa S, Kawano M. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther. 2017;19:262.","journal-title":"Arthritis Res Ther"},{"key":"494_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14397595.2018.1554321","volume":"29","author":"M Kawano","year":"2019","unstructured":"Kawano M, Saeki T, Nakashima H. IgG4-related kidney disease and retroperitoneal fibrosis: an update. Mod Rheumatol. 2019;29:231\u20139.","journal-title":"Mod Rheumatol"},{"key":"494_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5414\/CNP71173","volume":"71","author":"T Saeki","year":"2009","unstructured":"Saeki T, Imai N, Ito T, Yamazaki H, Nishi S. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol. 2009;71:173\u20138.","journal-title":"Clin Nephrol"},{"key":"494_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/ki.2012.454","volume":"83","author":"JH Stone","year":"2013","unstructured":"Stone JH. IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease. Kidney Int. 2013;83:348\u201350.","journal-title":"Kidney Int"},{"key":"494_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ki.2012.382","volume":"83","author":"MP Alexander","year":"2013","unstructured":"Alexander MP, Larsen CP, Gibson IW, Nasr SH, Sethi S, Fidler ME, Raissian Y, Takahashi N, Chari S, Smyrk TC, Cornell LD. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83:455\u201362.","journal-title":"Kidney Int"},{"key":"494_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/modpathol.2012.207","volume":"26","author":"CP Larsen","year":"2013","unstructured":"Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26:709\u201315.","journal-title":"Mod Pathol"},{"key":"494_CR8","first-page":"138","volume":"3","author":"K Zheng","year":"2017","unstructured":"Zheng K, Teng F, Li XM. Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment. Chronic Dis Transl Med. 2017;3:138\u201347.","journal-title":"Chronic Dis Transl Med"},{"key":"494_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10157-015-1140-0","volume":"20","author":"T Saeki","year":"2016","unstructured":"Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Ubara Y, Nakashima H, Ito T, Yamazaki H, Narita I, Saito T. Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction. Clin Exp Nephrol. 2016;20:87\u201393.","journal-title":"Clin Exp Nephrol"},{"key":"494_CR10","doi-asserted-by":"publisher","first-page":"21337","DOI":"10.18632\/oncotarget.25095","volume":"9","author":"G Quattrocchio","year":"2018","unstructured":"Quattrocchio G, Barreca A, Demarchi A, Solfietti L, Beltrame G, Fenoglio R, Ferro M, Mesiano P, Murgia S, Del Vecchio G, Massara C, Rollino C, Roccatello D. IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy. Oncotarget. 2018;9:21337\u201347.","journal-title":"Oncotarget"},{"key":"494_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.ajkd.2011.05.006","volume":"58","author":"FC Fervenza","year":"2011","unstructured":"Fervenza FC, Downer G, Beck LH, Sethi S. IgG4-related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis. 2011;58:320\u20134.","journal-title":"Am J Kidney Dis"},{"key":"494_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.ajkd.2011.05.002","volume":"58","author":"P Cravedi","year":"2011","unstructured":"Cravedi P, Abbate M, Gagliardini E, Galbusera M, Buelli S, Sabadini E, Maras\u00e0 M, Beck LH Jr, Salant DJ, Benigni A, D'Agati V, Remuzzi G. Membranous nephropathy associated with IgG4-related disease. Am J Kidney Dis. 2011;58:272\u20135.","journal-title":"Am J Kidney Dis"},{"key":"494_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5414\/CN107037","volume":"77","author":"N Jindal","year":"2012","unstructured":"Jindal N, Yadav D, Passero C, Krasinskas A, Craig F, Bastacky S, Liang KV. Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease. Clin Nephrol. 2012;77:321\u20138.","journal-title":"Clin Nephrol"},{"key":"494_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/ckj\/sft062","volume":"6","author":"Y Wada","year":"2013","unstructured":"Wada Y, Saeki T, Yoshita K, Ayalon R, Kamimura K, Nakano M, Narita I. Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathy. Clin Kidney J. 2013;6:486\u201390.","journal-title":"Clin Kidney J"},{"key":"494_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/ckj\/sfs180","volume":"6","author":"H Kanda","year":"2013","unstructured":"Kanda H, Koya J, Uozaki H, Tateishi S, Sato K, Hagino N, Sawada T, Yamamoto K. Membranous nephropathy with repeated flares in IgG4-related disease. Clin Kidney J. 2013;6:204\u20137.","journal-title":"Clin Kidney J"},{"key":"494_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10067-013-2406-0","volume":"33","author":"XL Li","year":"2014","unstructured":"Li XL, Yan TK, Li HF, Xu PC, Jia JY, Wei L, Shang WY, Lin S. IgG4-related membranous nephropathy with high blood and low urine IgG4\/IgG ratio: a case report and review of the literature. Clin Rheumatol. 2014;33:145\u20138.","journal-title":"Clin Rheumatol"},{"key":"494_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s13730-013-0077-y","volume":"3","author":"S Sueta","year":"2014","unstructured":"Sueta S, Kondo M, Matsubara T, Yasuhara Y, Akiyama S, Imai E, Amaike H, Tagawa M. Membranous nephropathy associated with type 1 autoimmune pancreatitis and dominant glomerular IgG4 deposit. CEN Case Rep. 2014;3:18\u201323.","journal-title":"CEN Case Rep"},{"key":"494_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ckj\/sfu077","volume":"7","author":"A Omokawa","year":"2014","unstructured":"Omokawa A, Komatsuda A, Hirokawa M, Wakui H. Membranous nephropathy with monoclonal IgG4 deposits and associated IgG4-related lung disease. Clin Kidney J. 2014;7:475\u20138.","journal-title":"Clin Kidney J"},{"key":"494_CR19","first-page":"678538","volume":"2014","author":"KN Miyata","year":"2014","unstructured":"Miyata KN, Kihira H, Haneda M, Nishio Y. IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine. Case Rep Nephrol. 2014;2014:678538.","journal-title":"Case Rep Nephrol"},{"key":"494_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/0971-4065.143300","volume":"25","author":"AA Kurien","year":"2015","unstructured":"Kurien AA, Raychaudhury A, Walker PD. Membranous nephropathy as a rare renal manifestation of IgG4-related disease. Indian J Nephrol. 2015;25:164\u20137.","journal-title":"Indian J Nephrol"},{"key":"494_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000369924","volume":"5","author":"K Stylianou","year":"2015","unstructured":"Stylianou K, Maragkaki E, Tzanakakis M, Stratakis S, Gakiopoulou H, Daphnis E. Acute Interstitial Nephritis and Membranous Nephropathy in the Context of IgG4-Related Disease. Case Rep Nephrol Dial. 2015;5:44\u20138.","journal-title":"Case Rep Nephrol Dial"},{"key":"494_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/14397595.2016.1245238","volume":"29","author":"S Horita","year":"2019","unstructured":"Horita S, Fujii H, Mizushima I, Fujisawa Y, Hara S, Yamada K, Inoue D, Nakajima K, Harada K, Kawano M. A case of IgG4-related tubulointerstitial nephritis and membranous glomerulonephritis during the clinical course of gastric cancer: Imaging features of IgG4-related kidney disease. Mod Rheumatol. 2019;29:542\u20136.","journal-title":"Mod Rheumatol"},{"key":"494_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5414\/CN108888","volume":"86","author":"M Acevedo Rib\u00f3","year":"2016","unstructured":"Acevedo Rib\u00f3 M, Ahijado Hormigos FJ, D\u00edaz F, Romero Molina M, Fernandez Rojo MA, Garcia Rubiales MA, Garc\u00eda DE. IgG4-related disease and idiopathic membranous nephropathy: \"The clothes do not make the man\". Clin Nephrol. 2016;86:345\u20138.","journal-title":"Clin Nephrol"},{"key":"494_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12882-017-0561-2","volume":"18","author":"J Huart","year":"2017","unstructured":"Huart J, Grosch S, Bovy C, Moutschen M, Krzesinski JM. IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report. BMC Nephrol. 2017;18:139.","journal-title":"BMC Nephrol"},{"key":"494_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13730-018-0311-8","volume":"7","author":"W Zhang","year":"2018","unstructured":"Zhang W, Glaze JH, Wynne D. Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review. CEN Case Rep. 2018;7:137\u201342.","journal-title":"CEN Case Rep"},{"key":"494_CR26","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.2169\/internalmedicine.0836-18","volume":"57","author":"H Arai","year":"2018","unstructured":"Arai H, Toda N, Kamimatsuse R, Nishioka K, Endo S, Akiyama S, Maruyama S, Matsubara T, Yokoi H, Yanagita M. A refractory case of secondary membranous nephropathy concurrent with IgG4-related tubulointerstitial nephritis. Intern Med. 2018;57:2873\u20137.","journal-title":"Intern Med"},{"issue":"20","key":"494_CR27","doi-asserted-by":"publisher","first-page":"e15616","DOI":"10.1097\/MD.0000000000015616","volume":"98","author":"SA Muhsin","year":"2019","unstructured":"Muhsin SA, Masia R, Smith RN, Wallace ZS, Perugino CA, Stone JH, Niles JL, Cortazar FB. Phospholipase A2 receptor-associated membranous nephropathy in a patient with IgG4-related disease: a case report. Medicine (Baltimore). 2019;98(20):e15616.","journal-title":"Medicine (Baltimore)"},{"key":"494_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s10157-013-0930-5","volume":"18","author":"E Muso","year":"2014","unstructured":"Muso E. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome. Clin Exp Nephrol. 2014;18:286\u201390.","journal-title":"Clin Exp Nephrol"},{"key":"494_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10157-014-0996-8","volume":"19","author":"E Muso","year":"2015","unstructured":"Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Yuzawa Y, Takemura T, Sugiyama S, Nishizawa Y, Ogahara S, Yorioka N, Sakai S, Ogura Y, Yukawa S, Iino Y, Imai E, Matsuo S, Saito T. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study. Clin Exp Nephrol. 2015;19:379\u201386.","journal-title":"Clin Exp Nephrol"},{"key":"494_CR30","first-page":"1153","volume":"30","author":"K Tojo","year":"1988","unstructured":"Tojo K, Sakai S, Miyahara T. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS). Nihon Jinzo Gakkai Shi. 1988;30:1153\u201360.","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"494_CR31","first-page":"257","volume":"9","author":"E Muso","year":"1994","unstructured":"Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant. 1994;9:257\u201364.","journal-title":"Nephrol Dial Transplant"},{"key":"494_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0041-1345(99)00941-0","volume":"32","author":"T Ideura","year":"2000","unstructured":"Ideura T, Hora K, Kaneko Y, Yamazaki T, Tokunaga S, Shigematsu H, Kiyosawa K. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report. Transplant Proc. 2000;32:223\u20136.","journal-title":"Transplant Proc"},{"key":"494_CR33","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.2169\/internalmedicine.51.7204","volume":"51","author":"Y Sato","year":"2012","unstructured":"Sato Y, Tsunoda S, Nozue T, Pan Q, Wakasugi H, Yoshimura A. Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy. Intern Med. 2012;51:2597\u2013602.","journal-title":"Intern Med"},{"key":"494_CR34","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2169\/internalmedicine.56.8081","volume":"56","author":"J Yabuuchi","year":"2017","unstructured":"Yabuuchi J, Suwabe T, Mizuno H, Ueno T, Hoshino J, Sekine A, Kawada M, Yamanouchi M, Hayami N, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K, Fujii T, Ohashi K, Ubara Y. Long-term low-density lipoprotein apheresis in a patient with refractory idiopathic membranous glomerulonephritis. Intern Med. 2017;56:1543\u20137.","journal-title":"Intern Med"},{"key":"494_CR35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jca.21677","volume":"34","author":"JM Szymanski","year":"2019","unstructured":"Szymanski JM, Waldman M, Conry-Cantilena C, West KA. Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis. J Clin Apher. 2019;34:495\u20138.","journal-title":"J Clin Apher"},{"key":"494_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/1744-9987.12811","volume":"23","author":"E Koshi-Ito","year":"2019","unstructured":"Koshi-Ito E, Koike K, Tanaka A, Watanabe Y, Kamegai N, Shimogushi H, Shinjo H, Otsuka Y, Inaguma D, Takeda A. Effect of low-density lipoprotein apheresis for nephrotic idiopathic membranous nephropathy as initial induction therapy. Ther Apher Dial. 2019;23:575\u201383.","journal-title":"Ther Apher Dial"},{"key":"494_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ndt\/15.2.235","volume":"15","author":"S Daimon","year":"2000","unstructured":"Daimon S, Saga T, Nakayama M, Nomura Y, Chikaki H, Dan K, Koni I. Dextran sulphate cellulose columns for the treatment of nephrotic syndrome due to inactive lupus nephritis. Nephrol Dial Transplant. 2000;15:235\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"494_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1159\/000045113","volume":"79","author":"S Kobayashi","year":"1998","unstructured":"Kobayashi S. LDL-Apheresis for diabetic nephropathy: a possible new tool. Nephron. 1998;79:505\u20136.","journal-title":"Nephron"},{"key":"494_CR39","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/nep.12711","volume":"21","author":"A Tanaka","year":"2016","unstructured":"Tanaka A, Nakamura T, Sato E, Node K. Impact of low-density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy. Nephrology (Carlton). 2016;21:1073\u20134.","journal-title":"Nephrology (Carlton)"},{"key":"494_CR40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/1744-9987.12411","volume":"20","author":"Y Ito","year":"2016","unstructured":"Ito Y, Inoue T, Okada H. Successful treatment of C1q nephropathy by low-density lipoprotein apheresis. Ther Apher Dial. 2016;20:530\u20131.","journal-title":"Ther Apher Dial"},{"key":"494_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5414\/CNP61429","volume":"61","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Kawagoe Y, Matsuda T, Ueda Y, Koide H. Low-density lipoprotein apheresis in a patient with arteriosclerosis obliterans and light chain deposition disease. Clin Nephrol. 2004;61:429\u201333.","journal-title":"Clin Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00494-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-020-00494-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00494-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T13:40:59Z","timestamp":1696254059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-020-00494-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00494-6","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}